The knowledge, perceptions and practice of pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 1, 2011, Pages 30-35

  Oreagba, I A ^a,c   Ogunleye, O J ^b   Olayemi, S O ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b Faculty of Pharmacy   (Nigeria)

^c Drug Administration and Control Abuja Nigeria   (Nigeria)

Author keywords

Adverse drug reactions; Community pharmacists; Pharmacovigilance

Indexed keywords

ADULT; AGED; ARTICLE; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL PRACTICE; NIGERIA; PHARMACIST; PRIORITY JOURNAL;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NIGERIA; PHARMACEUTICAL PREPARATIONS; PHARMACIES; PHARMACISTS; PRODUCT SURVEILLANCE, POSTMARKETING; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 78650398029     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2021     Document Type: Article

References (16)

1. Safety Monitoring of Medicinal Products: Guidelines for setting up and running a Pharmacovigilance Centre UMC 2000.
2. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol 2004; 18(3): 275-280.
3. Wiholm BE, Olsson S, Moore N, Wood S. Spontaneous reporting systems outside the United States. In Strom BL (eds). Pharmacoepidemiology. John Wiley & Sons Ltd: Chichester, 1994; p. 139-55.
4. PGEU statement "Pharmacists' Involvement in Pharmacovigilance Systems 2005.
5. Van Grootheest AC, van Puijenbroek EP, de Jong-van den Berg LTW. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 205-210.
6. Olsson S. National Pharmacovigilance Systemsd Country Profiles and Overview, (2nd edn) Uppsala Monitoring Centre: Uppsala, 1999.
7. THE AUTHENTIC CENSUS: Lagos State Social Security Exercise and Population Accessed March 2, 2010.
8. WHO. Pharmacovigilance: ensuring the safe use of medicines. WHO Policy Perspectives on Medicines, Geneva, Switzerland; 2004; Accessed Oct 26th, 2007.
9. Ohaju-Obodo JO, Iribhogbe OI. Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria. Pharmacoepidemiol Drug Saf 2009; 19(2): 191-195. DOI: 10.1002/pds.1724.
10. Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci 2008; 30(5): 556-562.
11. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci 2009; 31: 183-187 185.
12. Figueiras A, Tato F, Fontainas JBS, et al. Influence of physicians attitudes on reporting adverse drug events: a case-control study. Med Care J 1999; 37(8): 809-814.
13. Zoriah A, Tan CS, Nurul SB. Reporting of adverse drug reactions; prediction of under-reporting in Malaysia. Pharmacoepidemiol Drug Saf 2007; 16(2): 223.
14. van Grootheest AC, Mes K, de Jong-van den Berg LTW. Attitudes of community pharmacists in the Netherlands towardsADRreporting. Int J Pharm Pract 2002; 10: 267-272.
15. Green CF, Mottram DR, Raval D, Proudlove C, Randall C. Community pharmacists' attitude to adverse drug reaction reporting. Int J Pharm Pract 1999; 7: 92-99.
16. Oreagba IA. Pharmacovigilance and the Role of Hospital and Community Pharmacists. Nig J Pharm 42(2): 24-28 November 2009.